Stories of patients with long term durable responses to cell and gene therapies make headlines in the media and bring hope to patients in need of treatment options. However, bringing these ATMPs to patients requires navigating a complex and evolving landscape of increasingly efficient trial design, a fast-changing treatment landscape, successful navigation of the regulatory environment, a robust and scalable cell manufacturing process, as well as a patient ecosystem equipped to handle the unique challenges of treating patients with innovative new options.

As stakeholders with a shared vision of creating momentum in accelerating access to ATMPs, Flemingsberg Science Foundation and Miltenyi Biotec Nordics are proud to host an educational seminar aimed at highlighting challenges and opportunities in meeting patient needs at every step of the journey from pre-GMP development through clinical trials. Join the engaged and supportive community of local cell therapy experts and enthusiasts in addressing the challenge of bringing more ATMP options to more patients, more efficiently.

This educational event promoted under the ATMP Flemingsberg brand, a platform created by Flemingsberg Science to showcase ATMP development in the region. Attendance is free of charge and open to practicing scientists and healthcare professionals from Academia and Industry. Refreshments will be served.